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Human African trypanosomiasis
(HAT), also known as sleeping sickness, is
a neglected disease that impacts 70 million
people distributed over 1.55 million km2 in
sub-Saharan Africa [1]. Trypanosoma brucei
gambiense accounts for almost 90% of the
infections in central and western Africa,
the remaining infections being from T. b.
rhodesiense in eastern Africa [1]. Further-
more, the animal diseases caused by
related parasites inflict major economic
losses to countries already strained [2].
The parasites are transmitted to the
mammalian hosts through the bite of an
infected tsetse fly.
In the early part of the 20th century,
HAT epidemics decimated human popu-
lations in many parts of Africa. In the
1930s, systematic screening, treatment,
and follow-up of millions of individuals
by the colonial administrations led to a
dramatic decrease in disease transmission
(reviewed in [3]). Following independence
in the 1950–60s, HAT control efforts in
most African countries were relaxed and
taken over by other priorities in light of the
decline in disease incidence. Unfortunate-
ly, the disease slowly returned, with flare-
ups beginning to be reported throughout
the endemic areas by the late 80s and early
90s [4,5,6]. In a 1997 resolution, WHO
strongly advocated access to diagnosis and
treatment with surveillance and control
activities, concurrently setting up a network
to strengthen coordination among endemic
countries [7,8]. Sadly, the disease killed
thousands of people before control measures
began to take effect [9]. In 2006, 20 out of
the 36 endemic countries had achieved the
target of no new cases, and eight countries
reported fewer than 100 cases. In 2008,
WHO declared that the newly reported
cases had dramatically declined to fewer
than 10,000 continent-wide and called for
plans towards a HAT elimination policy
[10]. The gambiense form of the disease has
been targeted for elimination by 2020 [11].
It is important to note, however, that
estimating the true burden of HAT is
difficult, as the disease affects the most
neglected populations, living in remote and
rural settings where the majority of people
affected are beyond the reach of health care
systems and are not reported in the health
metrics [12]. It is also important to be
mindful of ongoing political conflicts, which
stand to refuel the emergence of epidemics
unless control measures continue to be
employed in endemic countries [13,14,15].
Thus, it is imperative that endemic coun-
tries must at least continue to retain
mechanisms and health personnel who can
recognize and report potential HAT cases to
prevent reemergence of the disease [16]. A
flexible set of control efforts needs to be
adapted to the different epidemiological
patterns in order to adopt the most adequate
strategies for maintaining cost-effectiveness
[17,18].
Achieving disease control in the mam-
malian host has been challenging given the
lack of effective mammalian vaccines and
cheap and easily deliverable drugs. Fur-
thermore, at times of low endemicity,
relying on active surveillance of human
infections is not cost-effective. The chal-
lenge now is to identify control methods
that will ensure that the continent remains
free of HAT. One approach that has
worked well to curb disease is the
reduction of tsetse vector populations.
This is due to the low reproductive rate
of tsetse resulting from its viviparous
biology. Improving the efficacy of the
currently available vector control tools
(targets, traps, and insecticide applications)
or enhancing the implementation of con-
trol programs that utilize this set of tools in
different ecological settings can improve
effectiveness. Also, the effectiveness of
these tools can be improved through a
better understanding of tsetse physiolo-
gy—a feature that has enabled the devel-
opment of these tools in the first place.
The complete genome sequence informa-
tion from Glossina morsitans morsitans, pub-
lished in Science this week, now provides a
unique opportunity to transform tsetse
research and disease control practices
[19]. Particularly important in this regard
is knowledge of tsetse’s vision, olfactory,
immune, digestive and reproductive phys-
iology. The eight research papers pub-
lished this week PLOS-wide that accom-
pany the tsetse genome paper already
point to unique opportunities for improv-
ing control (see Tsetse Genome Biology
Collection).
Getting at the genome data, however,
has not been an easy road. The Glossina
community was small, and many of the
facilities in Africa that maintained tsetse fly
colonies and conducted research on this
vector were beginning to downsize their
programs in the early 2000s due to
reduced research funds, despite the rising
disease incidence. A small group of
researchers, however, argued that moving
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tsetse research into the -omics era would
provide new stimulus that would give rise
to opportunities for control and, impor-
tantly, would attract young researchers to
the field of tsetse research [20]. The
Molecular Entomology work area of the
Special Programme for Research and
Training in Tropical Diseases (TDR) at
the World Health Organization (WHO)
funded the establishment of a consortium
(International Glossina Genome Initiative
[IGGI]) in 2004 that brought together an
interdisciplinary group of researchers from
multiple institutions to chart the course
towards the finish line [20,21]. The
consortium recruited global funds that
enabled the development of a molecular
toolbox, which initially included data from
several large expressed-sequence (EST)
libraries along with construction and
sequencing of a Bacterial Artificial Chro-
mosome (BAC) library. Given that the
tsetse vector and the disease is endemic to
sub-Sahara Africa, IGGI membership
chose to use this networking opportunity
to help build research capacity in Africa
on genetics and genomics aspects of tsetse
[21]. In the following seven years, the
IGGI consortium met yearly for coordi-
nation meetings, organized five bioinfor-
matics workshops that trained students
and junior faculty from endemic countries,
and set up exchange programs for students
and researchers from Africa to be trained
in research laboratories in Europe and the
United States. Over 40 African students
and researchers from African institutions
attended a transcriptome analysis jambo-
ree held at the South African National
Bioinformatics Institute (SANBI) in 2007.
The genome project led by the Sanger
Institute also benefited from the contribu-
tions of many genome centers, including
TIGR in the US, RIKEN in Japan, and
Genoscope in France. Two manual com-
munity annotation workshops and the 146
experts recruited from the broad vector
community helped the program to reach
the finish line this month. Building on
their success story with Glossina morsitans
genome, the consortium has now secured
funds from the National Institute of
Health in the US to sequence five
additional species of Glossina at the Uni-
versity of Washington Genome Center,
and this project is nearly complete.
The PLOS-wide collection, titled Tsetse
Genome Biology, accompanying this issue
presents two Historical Perspective articles
that review events related to the devastat-
ing HAT epidemics in the early years of
the 20th century [22,23]. In addition, the
collection has eight research articles that
expand on the genome discoveries and
report on several low hanging fruits that
are ready for exploitation for improved
vector control. One of these discoveries is
related to the tsetse olfactory system,
which appears to be significantly stream-
lined when compared to other disease
vectors, such as mosquitoes [24]. At the
core of the success of the trapping devices
is the ability of tsetse to recognize the color
blue and be attracted to certain smells,
which are used as bait. The availability of
the full spectrum of olfactory components
now stands to provide new or more effective
species-specific attractants that can improve
the efficacy of traps. Another area that is
unique among disease vectors is tsetse’s
viviparous reproductive system, which in-
volves the production of one progeny at a
time that is nourished by the milk secretions
of the mother during intrauterine develop-
ment. Each female can produce on average
eight to ten progeny, and she remains
fecund during much of her adult life. This
low reproductive capacity is at the core of
the success of strategies that aim to reduce
tsetse populations. To nurture its developing
larva, the tsetse female lactates and produc-
es milk. Researchers have now identified a
previously unknown group of indispensable
milk proteins that are coordinately synthe-
sized during the lactation phase. Without
these proteins, the female cannot support
her developing larva [25]. Interestingly, a
single transcription factor, the homeobox
factor Ladybird Late, may be responsible
for the coordinated expression of all milk
proteins, opening the way for future novel
biological strategies that target tsetse’s
lactation cycle and associated reproductive
capacity [26]. In addition, lactation-specific
aquaporin proteins were also identified and
are needed for water transport and hydra-
tion during milk synthesis [27]. Finally,
comparison of before and after pregnancy
transcriptomes indicates that prevention of
oxidative stress may be the key for the
success of the prolonged reproductive
output and longevity associated with tsetse
female physiology [28].
Tsetse carries with it multiple symbiotic
microbes, one of which is called Wolba-
chia. Wolbachia has been shown to manip-
ulate host reproductive physiology in
many insects, including in tsetse [29].
One of the research papers in the
collection describes the Whole Genome
Sequence of the Wolbachia symbiont
obtained from the same Glossina morsitans
species [30]. This study also reports that
unusually large sections of the genome of
the Wolbachia symbiont have been trans-
ferred to the host tsetse genome, partic-
ularly residing in the sex chromosomes
[30].
Finally, although extensive research has
been conducted on African trypanosomes
in the mammalian host, knowledge of
tsetse–parasite interactions remains sparse.
An area of interest has been discovery of
tsetse mechanisms that can block parasite
transmission either in the midgut or in the
salivary glands. This is of interest to both
basic and applied research since the ability
to engineer greater resistance in flies could
solve the problem of disease transmission.
Researchers characterized important tset-
se genes whose products are components
of physical and immunological barriers in
the gut Peritrophic Matrix (PM) to try-
panosome infections [31]. Another study
has compared trypanosome and tsetse
transcriptomes from normal and parasit-
ized salivary glands, as well as from
normal and parasitized mammalian blood
[32]. This study reports on parasite
adaptations that may enable its survival
in the two different host environments and
host gene expression modifications that
may help parasite survival in either the
salivary gland or, possibly, in the mam-
malian bite site [32].
The wealth of information that is
revealed from the genome and func-
tional genomics data is now ready to be
explored and exploited. The soon-to-be-
available additional Glossina genomes
will shed light onto the species-specific
habitat and vertebrate host require-
ments and varying vector competence
associated with the different species.
Thus, money was well spent on the
small investment made by WHO-TDR
to bring together IGGI. An important
goal of the genome project was expan-
sion of the community of tsetse re-
searchers—the consortium now invites
all interested researchers, particularly
junior scientists, to take a look at
research opportunities on tsetse and
trypanosomes. The consortium hopes
that while HAT is a neglected tropical
disease, vector tsetse research may enjoy
broader participation from the vector
community and lead to improved and/
or novel methods to eliminate disease.
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